Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2026-03-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
独立董事2025年度述职报告（厉国威）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director of Zhejiang Tailin Biotechnology Co., Ltd. for the year 2025. It includes the director's personal background, attendance at board and shareholder meetings, committee work, communication with auditors, supervision of company governance and internal controls, and overall evaluation and suggestions for the next year. The document is not a financial report, earnings release, or regulatory filing but a management-related report focusing on the director's duties and governance role. It does not announce voting results, capital changes, or legal proceedings. The content aligns with a Board/Management Information report, specifically an independent director's annual work report. The document length is 3117 characters, which is sufficient for a detailed report but not a full annual report or audit report. Therefore, the best fitting category is Board/Management Information (MANG).
2026-03-26 Chinese
2025年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the fiscal year ending December 31, 2025, issued by Zhejiang Tailin Biotechnology Co., Ltd. It extensively discusses the company's internal control systems, governance structure, risk management, and evaluation of internal control effectiveness. The content includes detailed descriptions of internal control procedures, defect identification standards, and corrective measures. It is a comprehensive report on internal control evaluation rather than a general annual report or financial statement. The document is over 10,000 characters, indicating it is a full report, not a brief announcement. The focus on internal control self-evaluation aligns with the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-03-26 Chinese
2025年度财务决算报告
Annual Report Classification · 95% confidence The document is titled '2025 年度财务决算报告' which translates to '2025 Annual Financial Settlement Report'. It includes audited financial statements for the year 2025, with detailed financial data such as total assets, liabilities, equity, operating income, profit, and cash flow. The audit opinion is from a certified accounting firm with a standard unqualified opinion, indicating this is a formal audited financial report. The presence of comprehensive financial statements and audit opinion for a full fiscal year strongly indicates this is an Annual Report. The document length is 1575 characters, which is short, but the content includes substantive financial data and audit results, not just an announcement or certification. Therefore, it is classified as an Annual Report (10-K). FY 2025
2026-03-26 Chinese
第四届董事会第十一次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 11th meeting of the 4th Board of Directors of Zhejiang Tailin Biotechnology Co., Ltd. It includes approvals of the 2025 Annual Report, financial statements, profit distribution plan, audit reports, internal control reports, and various proposals related to the issuance of convertible bonds. The document contains extensive details on the convertible bond issuance plan, including terms, conditions, pricing, redemption, and use of proceeds. It also references multiple reports and documents published on the official disclosure website but does not itself contain the full annual report or financial statements. The document is a formal board meeting resolution announcement covering multiple governance and financing matters, especially focusing on capital raising via convertible bonds. Given the comprehensive nature of board decisions and management reports but the primary focus on board resolutions and financing plans, the best classification is "Capital/Financing Update (CAP)". It is not a full Annual Report (10-K) or Audit Report (AR) because it does not contain the full financial statements or audit opinions but rather approvals and plans. It is not a Management Report (MDA) because it is a board meeting resolution document. It is not a Regulatory Filing (RNS) because it is a formal announcement of board resolutions. Therefore, the document is best classified as a Capital/Financing Update (CAP). Confidence is high due to the detailed financing and bond issuance content and board meeting context.
2026-03-26 Chinese
2025年度利润分配方案
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the 2025 annual profit distribution plan. It details the board and independent directors' approval of the dividend payout, the amount of cash dividends per share, and the rationale behind the distribution. It includes financial figures such as net profit, undistributed profits, and dividend amounts, but it is primarily focused on the dividend distribution proposal and related approvals rather than presenting a full financial report or audit. The document is relatively short (2954 characters) and structured as an announcement of a profit distribution plan to shareholders, which aligns with a Notice of Dividend Amount filing. It is not a full Annual Report, Interim Report, or Earnings Release, nor is it a proxy solicitation or management discussion. Therefore, the best classification is Notice of Dividend Amount (DIV).
2026-03-26 Chinese
独立董事2025年度述职报告（董明）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director for the year 2025 at Zhejiang Tailin Biotechnology Co., Ltd. It includes the director's attendance at board and shareholder meetings, committee work, communication with auditors, oversight of related party transactions, and other governance activities. The content focuses on the director's duties, compliance with laws and regulations, and governance matters rather than financial results or audit opinions. It is not a full annual report (10-K), audit report (AR), or management discussion and analysis (MDA). It is also not a brief announcement or a proxy solicitation. The document is a formal report by a board member on their activities and governance role, fitting the category of Board/Management Information (MANG). The document length is 4579 characters, which is substantial and contains detailed narrative rather than just an announcement or certification. Therefore, the best classification is MANG with high confidence.
2026-03-26 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.